Ad
ALNY - Alnylam Pharmaceuticals Stock Trading
About | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
Not available
Quote | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
| Last: | $188.26 |
|---|---|
| Change Percent: | -0.27% |
| Open: | $186.5 |
| Close: | $188.26 |
| High: | $188.87 |
| Low: | $184.06 |
| Volume: | 426,665 |
| Last Trade Date Time: | 05/26/2023 03:00:00 am |
News | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
-
2023-05-22 17:43:28 ET Summary BioNTech SE has initiation of a phase 3 study using BNT316 as a monotherapy for PD-1/PD-L1 refractory non-small cell lung cancer patients that is expected to take place in 2023. Updated results from the expansion cohort from phase 1/2 study using BNT...
-
– Continued Treatment with Patisiran in Open-Label Extension Period Showed Evidence of Sustained Benefit across Measures of Functional Capacity and Health Status and Quality of Life, as well as Cardiac Stress and Injury, through 18 Months – – Safety Profil...
Message Board Posts | Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)
| Subject | By | Source | When |
|---|---|---|---|
| whytestocks: $ALNY News Article - Alnylam to Present Additional Data from the APOLLO-B Phase 3 Study | whytestocks | investorshangout | 09/13/2022 12:25:48 PM |
| whytestocks: $ALNY News Article - Alnylam Announces Pricing of Offering of $900 Million Convertible | whytestocks | investorshangout | 09/13/2022 12:20:47 PM |
| whytestocks: $ALNY News Article - Alnylam Presents Positive Results from the APOLLO-B Phase 3 Study | whytestocks | investorshangout | 09/08/2022 4:15:54 PM |
| whytestocks: $ALNY News Article - Alnylam to Webcast Presentation at Morgan Stanley 20th Annual Glob | whytestocks | investorshangout | 09/06/2022 12:20:48 PM |
| whytestocks: $ALNY News Article - Alnylam Announces Appointment of Elliott Sigal, M.D., Ph.D., to Bo | whytestocks | investorshangout | 08/24/2022 8:06:00 PM |
Alnylam Pharmaceuticals Inc. Company Name:
ALNY Stock Symbol:
NASDAQ Market:
Alnylam Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
